Capricor Therapeutics (CAPR) announced the appointment of Michael Binks, M.D., as Chief Medical Officer, effective immediately. Dr. Binks brings 25 years of experience leading global clinical development and translational research across the pharmaceutical and biotechnology sectors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor Therapeutics, Inc. (CAPR) Q1 Earnings Cheat Sheet
- Capricor FDA panel meeting ‘not unexpected,’ says JonesResearch
- Capricor share weakness unwarranted, says H.C. Wainwright
- Capricor completes mid-cycle review with FDA for BLA for deramiocel
- Vaccine, gene therapy makers fall after Peter Marks resignation
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue